from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3643/-

LFCtreatmentdescriptionclass of inhibitor

1.039

Amikacinug/mL Amikacintranslation

1.479

Cap5-10ug/mL Capreomycintranslation

0.170

Rox10-50 ug/mL Roxithromycintranslation

-0.196

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.353

Rif0.2-5ug/mL Rifampicintranscription

0.410

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.556

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.292

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

1.756

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-2.310

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.000

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.786

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.461

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.636

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.273

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

-0.433

NaN30.2-2 mM Sodium aziderespiration

-0.477

Nigericin50 uM Nigericinrespiration

0.363

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-1.232

Valinomycin0.5-10 uM Valinomycinrespiration

-0.252

ZnSO42 mM ZnSO4respiration

0.407

menadione6-10 ug/mL Menadionerespiration

0.682

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.297

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.319

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.640

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.123

NRP_1Non-replicating persistence stage 1dosRassociated

-0.240

Amp0.2mg/mL AmpicillincellWall

0.959

Cephalexin20-100 ug/mL CephalexincellWall

0.259

Cerulenin0.32-5 ug/mL CerulenincellWall

1.955

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.471

EMB10-20 ug/mL EthambutolcellWall

0.144

Eta12-40 ug/mL EthionamidecellWall

0.431

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.753

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.384

BZA0.12 mg/mL BenzamidearomaticAmides

-0.155

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.263

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.813

H2O24 mM hydrogen peroxideDNAdamaging

-0.151

Levo10 ug/mL LevofloxacinDNAdamaging

0.692

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.071

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.094

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.357

Antimycin12.5-50 ug/mL Antimycin A?

-0.654

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.167

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.260

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.759

PA8240.2-2 ug/mL PA-824?

0.364

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.992

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.443

Verapamil50 uM Verapamil?

-0.306

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.737

methoxatin10-20 ug/mL Methoxatin?